The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations

酰基富烯烷化剂 LP-184 在携带其他治疗难治性突变的非小细胞肺癌中保持纳摩尔效力